{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T01:19:31Z","timestamp":1768094371705,"version":"3.49.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Optimal medical therapy (OMT) plays a crucial role in the secondary prevention of established coronary artery disease. The renin\u2013angiotensin system (RAS) is an important target of OMT. However, there is limited evidence on whether there is any difference in the combined effect of OMT according to the classes of RAS blockade [angiotensin-converting enzyme inhibitor (ACEI) vs. angiotensin receptor blocker (ARB)]. Based on the nationwide National Health Insurance database in South Korea, 39,096 patients who received OMT after percutaneous coronary intervention between July 2013 and June 2017 were enrolled. Patients were stratified into either acute myocardial infarction (AMI) or angina cohort and analyzed according to the class of RAS blockade included in OMT at discharge (ACEI vs. ARB). The primary end point was all-cause mortality. The study population had a median follow-up of 2.3 years (interquartile range, 1.3\u20133.3 years). In the propensity score-matched AMI cohort (8219 pairs), the risk for all-cause mortality was significantly lower in patients with ACEI-based OMT than in those with ARB-based OMT (hazard ratio 0.83 of ACEI, 95% confidence interval 0.73\u20130.94, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003). However, in the propensity score-matched angina cohort (6693 pairs), the mortality risk was comparable, regardless of the class of RAS blockade (hazard ratio 1.13, 95 confidence interval 0.99\u20131.29, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.08). In conclusion, in this nationwide cohort study involving patients receiving OMT after percutaneous coronary intervention, ACEI-based OMT was associated with a significantly lower risk of all-cause mortality in patients with AMI in comparison with ARB, but not in those with angina.<\/jats:p>","DOI":"10.1097\/fjc.0000000000000930","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T03:00:10Z","timestamp":1604890810000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Angiotensin-Converting Enzyme Inhibitor\u2013based Versus Angiotensin Receptor Blocker\u2013based Optimal Medical Therapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study"],"prefix":"10.1097","volume":"77","author":[{"given":"Sangwoo","family":"Park","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Giun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soe Hee","family":"Ann","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Soon Chun Hyang University Hospital Bucheon, Bucheon, Republic of Korea;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Soon Chun Hyang University Hospital Bucheon, Bucheon, Republic of Korea;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyung","family":"Roh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Republic of Korea;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Rak","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Dong-A University Hospital, Busan, Republic of Korea; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungbong","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Applied Statistics, Gachon University, Seongnam, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyung-Min","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa1505532","article-title":"Effect of PCI on long-term survival in patients with stable ischemic heart disease","volume":"373","author":"Sedlis","year":"2015","journal-title":"N Engl J Med."},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","article-title":"Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up","volume":"131","author":"Iqbal","year":"2015","journal-title":"Circulation."},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med."},{"key":"R4-20250802","first-page":"407","article-title":"ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J. 2019"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American heart association and American college of cardiology foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation."},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status","volume":"160","author":"Ma","year":"2010","journal-title":"Br J Pharmacol."},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2017","journal-title":"Eur Heart J."},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2015","journal-title":"Eur Heart J."},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2019.11.086","article-title":"Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention","volume":"306","author":"Ann","year":"2020","journal-title":"Int J Cardiol."},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jjcc.2016.05.005","article-title":"Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study)","volume":"69","author":"Lemesle","year":"2017","journal-title":"J Cardiol."},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"e007526","DOI":"10.1161\/JAHA.117.007526","article-title":"Variations in Use of Optimal Medical Therapy in Patients With Nonobstructive Coronary Artery Disease: A Population-Based Study","volume":"6","author":"Oxner","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamacardio.2017.2249","article-title":"Optimal Medical Therapy for Known Coronary Artery Disease: A Review","volume":"2","author":"Gibbons","year":"2017","journal-title":"JAMA Cardiol."},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCOUTCOMES.114.001305","article-title":"Model for assessing cardiovascular risk in a Korean population","volume":"7","author":"Park","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care."},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.athoracsur.2006.10.046","article-title":"Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery","volume":"83","author":"Goyal","year":"2007","journal-title":"Ann Thorac Surg."},{"key":"R18-20250802","first-page":"e574","article-title":"ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation."},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2018","journal-title":"Eur Heart J."},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet."},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40256-015-0140-5","article-title":"Comparative effectiveness of angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors following contemporary treatments in patients with acute myocardial infarction: results from the Korean working group in myocardial infarction (KorMI) registry","volume":"15","author":"Song","year":"2015","journal-title":"Am J Cardiovasc Drugs."},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.2011.601","article-title":"Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention","volume":"305","author":"Borden","year":"2011","journal-title":"JAMA."},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/HJH.0b013e3280bad9b4","article-title":"Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system","volume":"25","author":"Turnbull","year":"2007","journal-title":"J Hypertens."},{"key":"R24-20250802","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pcad.2015.11.004","article-title":"The divergent cardiovascular effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on myocardial infarction and death","volume":"58","author":"Strauss","year":"2016","journal-title":"Prog Cardiovasc Dis."},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1517\/13543784.17.9.1315","article-title":"Myocardial infarction, heart failure and sympathetic nervous system activity: new pharmacological approaches that affect neurohumoral activation","volume":"17","author":"Ciarka","year":"2008","journal-title":"Expert Opin Investig Drugs."},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1161\/01.CIR.90.4.2056","article-title":"Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection","volume":"90","author":"Lonn","year":"1994","journal-title":"Circulation."},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet."},{"key":"R28-20250802","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators","volume":"355","year":"2000","journal-title":"Lancet."},{"key":"R29-20250802","doi-asserted-by":"crossref","first-page":"j4","DOI":"10.1136\/bmj.j4","article-title":"Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials","volume":"356","author":"Bangalore","year":"2017","journal-title":"BMJ."},{"key":"R30-20250802","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ehjcvp\/pvv028","article-title":"Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study","volume":"1","author":"Ortolani","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"R31-20250802","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.108.824151","article-title":"Statin adherence and risk of accidents: a cautionary tale","volume":"119","author":"Dormuth","year":"2009","journal-title":"Circulation."}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FJC.0000000000000930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T22:04:52Z","timestamp":1754172292000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FJC.0000000000000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0000000000000930","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"2020-07-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}